Kumamoto University scientists developed new SARS-CoV-2 variant detection method
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Apr-2025 05:08 ET (19-Apr-2025 09:08 GMT/UTC)
Researchers at Kumamoto University have made a significant breakthrough in the fight against COVID-19 with the development of Intelli-OVI, a cutting-edge diagnostic tool capable of rapidly identifying emerging variants of the SARS-CoV-2 virus. This new system combines advanced DNA detection technology with computational algorithms to offer a quicker and more cost-effective method of monitoring viral mutations, which could play a crucial role in managing future pandemics.
Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of Covid-19. Moreover, the nanoparticles could be redesigned to target other pathogens.
A new study led by Rutgers Health researchers has uncovered important insights into vaccination patterns among LGBTQ+ adults in New Jersey and New York. The findings, published in the journal Vaccine, shed light on disparities in vaccine uptake within this diverse population.
the study highlights that LTV is more effective than NTV and ETV against Mpro mutants, making it a promising candidate for treating drug-resistant strains of SARS-CoV-2.
A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) sheds light on public trust in COVID-19 vaccine science and its impact on vaccine acceptance in the United States from 2021 to 2023.
A new study led by researchers at Albert Einstein College of Medicine involving more than 200,000 adults found that the COVID-19 pandemic caused a 29% increase in risk for developing dyslipidemia, a condition involving abnormal lipid (fat) levels in the blood. Seniors and people with type 2 diabetes were even more strongly affected, experiencing an approximately two-fold increased risk for developing dyslipidemia, which is a major risk factor for cardiovascular diseases such as heart attack and stroke. The research was published today in the print edition of The Journal of Clinical Investigation.
While the lockdowns associated with the COVID-19 pandemic led many families to eat more meals at home, they had an additional benefit: an increase in the quality of family time during those dinners, according to research published by the American Psychological Association.
Compared with just before the Covid-19 pandemic, people are spending nearly an hour less a day doing activities outside the home, behaviour that researchers say is a lasting consequence of the pandemic.
University of Queensland-led research has found inflammatory markers in the blood of long COVID patients which could explain why many experience ongoing cardiovascular issues.